Microsatellite Instability as an Emerging Biomarker for Checkpoint Inhibitor Response in Advanced Prostate Cancer

Zachery R. Reichert; Joshua Urrutia; Joshi J. Alumkal

doi:10.1001/jamaoncol.2018.5789

Microsatellite Instability as an Emerging Biomarker for Checkpoint Inhibitor Response in Advanced Prostate Cancer

Zachery R. Reichert, Joshua Urrutia, Joshi J. Alumkal

Hematology & Medical Oncology

Research output: Contribution to journal › Comment/debate › peer-review

4 Scopus citations

Original language	English (US)
Pages (from-to)	478-479
Number of pages	2
Journal	JAMA Oncology
Volume	5
Issue number	4
DOIs	https://doi.org/10.1001/jamaoncol.2018.5789
State	Published - Apr 2019

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1001/jamaoncol.2018.5789

Cite this

@article{4fab6782ed314d549dbed03d86566a3f,

title = "Microsatellite Instability as an Emerging Biomarker for Checkpoint Inhibitor Response in Advanced Prostate Cancer",

author = "Reichert, {Zachery R.} and Joshua Urrutia and Alumkal, {Joshi J.}",

note = "Funding Information: and institutional research funding from Aragon Pharmaceuticals Inc, Astellas Pharma, Novartis, Zenith Epigenetics Ltd, and Gilead Sciences Inc. No other disclosures were reported.",

year = "2019",

month = apr,

doi = "10.1001/jamaoncol.2018.5789",

language = "English (US)",

volume = "5",

pages = "478--479",

journal = "JAMA Oncology",

issn = "2374-2437",

publisher = "American Medical Association",

number = "4",

}

TY - JOUR

T1 - Microsatellite Instability as an Emerging Biomarker for Checkpoint Inhibitor Response in Advanced Prostate Cancer

AU - Reichert, Zachery R.

AU - Urrutia, Joshua

AU - Alumkal, Joshi J.

N1 - Funding Information: and institutional research funding from Aragon Pharmaceuticals Inc, Astellas Pharma, Novartis, Zenith Epigenetics Ltd, and Gilead Sciences Inc. No other disclosures were reported.

PY - 2019/4

Y1 - 2019/4

UR - http://www.scopus.com/inward/record.url?scp=85059261521&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059261521&partnerID=8YFLogxK

U2 - 10.1001/jamaoncol.2018.5789

DO - 10.1001/jamaoncol.2018.5789

M3 - Comment/debate

AN - SCOPUS:85059261521

SN - 2374-2437

VL - 5

SP - 478

EP - 479

JO - JAMA Oncology

JF - JAMA Oncology

IS - 4

ER -

Microsatellite Instability as an Emerging Biomarker for Checkpoint Inhibitor Response in Advanced Prostate Cancer

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this